Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial

IMPORTANCE: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst formation in both kidneys and loss of renal function, eventually leading to a need for kidney replacement therapy. There are limited therapeutic management options. OBJECTIVE: To examine the effect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA
Main Authors: Meijer, Esther, Visser, Folkert W., van Aerts, Rene M. M., Blijdorp, Charles J., Casteleijn, Niek F., D‘Agnolo, Hedwig M. A., Dekker, Shosha E. I., Drenth, Joost P. H., de Fijter, Johan W., van Gastel, Maatje D. A., Gevers, Tom J., Lantinga, Marten A., Losekoot, Monique, Messchendorp, A. Lianne, Neijenhuis, Myrte K., Pena, Michelle J., Peters, Dorien J. M., Salih, Mahdi, Soonawala, Darius, Spithoven, Edwin M., Wetzels, Jack F., Zietse, Robert, Gansevoort, Ron T.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2018
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6248170/
https://ncbi.nlm.nih.gov/pubmed/30422235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.15870
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados